CannaMore is a preclinical- and clinical-stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide. The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases. CannaMore is a portfolio company of BioSeedXL.